Macular Degeneration

Showing NaN - NaN of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)

Not yet recruiting
  • Geographic Atrophy of the Macula
  • Macular Degeneration
  • Saint Petersburg, Florida
  • +4 more
Apr 20, 2023

Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

Terminated
  • Dry Age-related Macular Degeneration
  • +4 more
  • Phoenix, Arizona
  • +28 more
Mar 22, 2022

Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration Trial in United States (GEM103, sham + SoC)

Completed
  • Neovascular Age-related Macular Degeneration
  • +3 more
  • GEM103
  • sham + SoC
  • Phoenix, Arizona
  • +22 more
Mar 22, 2022

Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)

Active, not recruiting
  • Geographic Atrophy
  • Macular Degeneration
  • Beverly Hills, California
  • +208 more
Sep 14, 2021

Natural Progression of Dry Age-related Macular Degeneration

Recruiting
  • Dry Age-related Macular Degeneration
  • +5 more
    • Phoenix, Arizona
    • +65 more
    Feb 22, 2021

    Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

    Completed
    • Dry Age-related Macular Degeneration
    • +4 more
    • GEM103
    • Phoenix, Arizona
    • +11 more
    Feb 9, 2021

    Macular Degeneration Trial in United States (Abicipar pegol)

    Completed
    • Macular Degeneration
    • Abicipar pegol
    • Phoenix, Arizona
    • +36 more
    Jul 17, 2020

    Macular Degeneration Trial in Worldwide (Abicipar Pegol, Ranibizumab, Sham Procedure)

    Completed
    • Macular Degeneration
    • Abicipar Pegol
    • +2 more
    • Phoenix, Arizona
    • +150 more
    Jul 16, 2020

    Geographic Atrophy, Macular Degeneration Trial in Worldwide (400 µg Brimonidine Implant, Sham)

    Terminated
    • Geographic Atrophy
    • Macular Degeneration
    • 400 µg Brimonidine Implant
    • Sham
    • Phoenix, Arizona
    • +40 more
    Mar 29, 2019

    Macular Degeneration Trial in United States (Abicipar pegol)

    Completed
    • Macular Degeneration
    • Abicipar pegol
    • Gilbert, Arizona
    • +17 more
    Feb 6, 2018

    Macular Degeneration Trial in Australia, Italy, United States (Pazopanib)

    Completed
    • Macular Degeneration
    • Beverly Hills, California
    • +16 more
    Oct 31, 2017

    Macular Degeneration Trial in Worldwide (Pazopanib)

    Completed
    • Macular Degeneration
    • Tucson, Arizona
    • +26 more
    Oct 18, 2017

    Macular Degeneration Trial in United States (Pazopanib)

    Completed
    • Macular Degeneration
    • Beverly Hills, California
    • +6 more
    Nov 7, 2017

    Macular Degeneration Trial in United States (TAC-PF, Triamcinolone Acetonide)

    Completed
    • Macular Degeneration
    • Tucson, Arizona
    • +22 more
    Jun 30, 2017

    Macular Degeneration Trial in Worldwide (rhuFab V2 (ranibizumab))

    Completed
    • Macular Degeneration
    • rhuFab V2 (ranibizumab)
    • Tucson, Arizona
    • +81 more
    Mar 18, 2014

    Macular Degeneration Trial in United States (VEGF Trap Eye)

    Completed
    • Macular Degeneration
    • VEGF Trap Eye
    • Peoria, Arizona
    • +32 more
    Jun 10, 2013

    Macular Degeneration Trial in Canada, United States (ranibizumab, aflibercept injection (VEGF Trap-Eye, BAY86-5321))

    Completed
    • Macular Degeneration
    • ranibizumab
    • aflibercept injection (VEGF Trap-Eye, BAY86-5321)
    • Birmingham, Alabama
    • +187 more
    Dec 20, 2012

    Macular Degeneration Trial in United States (aflibercept injection (VEGF Trap-Eye, BAY86-5321))

    Completed
    • Macular Degeneration
    • aflibercept injection (VEGF Trap-Eye, BAY86-5321)
    • Phoenix, Arizona
    • +17 more
    Jan 27, 2012

    Choroidal Neovascularization, Macular Degeneration Trial in Canada, United States (verteporfin, ranibizumab, dexamethasone)

    Completed
    • Choroidal Neovascularization
    • Macular Degeneration
    • Mobile, Alabama
    • +25 more
    May 31, 2011

    Macular Degeneration Trial in United States (MSI-1256F (Squalamine Lactate))

    Terminated
    • Macular Degeneration
    • MSI-1256F (Squalamine Lactate)
    • Boynton Beach, Florida
    • +8 more
    Nov 27, 2007